Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOSS-2: Cilostazol vs Clopidogrel in Intracranial Stenosis
NCT00130039Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Aug 2005
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, randomised, double-blind trial of cilostazol in intracranial atherosclerosis (ICAD) (2 arms), sponsored by Asan Medical Center. Primary endpoint: Progression rate of symptomatic intracranial stenosis at 7 months. Started Aug 2005; status: completed.
02
Drugs
cilostazol
03
Conditions
intracranial atherosclerosis (ICAD)
Beyond the preview
Go deeper on NCT00130039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130039.